Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof
US-2024390298-A1 · Nov 28, 2024 · US
US9447042B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9447042-B2 |
| Application number | US-201214000974-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 1, 2012 |
| Priority date | Mar 2, 2011 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): or a salt thereof as an active ingredient, and a method for controlling endoparasites, comprising orally or parenterally administering the endoparasite control agent.
Opening claim text (preview).
The invention claimed is: 1. A method for controlling endoparasites, wherein the endoparasite is selected from the subclass Rhabditia or Spiruria, in a mammal or bird, comprising orally or parenterally administering an effective amount of the endoparasite control agent comprising a carboxamide derivative represented by the general formula(I): wherein A represents a (C 1 -C 2 ) alkylene group which is optionally substituted by a (C 1 -C 6 ) alkyl group and/or a (C 3 -C 6 ) cycloalkyl group E represents a hydrogen atom, each X may be the same or different, and represents a halogen atom; or a (C 1 -C 6 ) alkyl group optionally substituted by a halogen atom; m represents an integer of 0, 1 or 2, each Y may be the same or different, and represents a halogen atom; a (C 1 -C 6 ) alkyl group optionally substituted by a halogen atom; n represents an integer of 0, 1, 2 or 3 and Z represents CH; or CY (wherein Y is as defined above), or a salt thereof as an active ingredient to said mammal or a bird. 2. The method according to claim 1 , wherein an effective amount of the endoparasite control agent is administered to a mammal. 3. The method according to claim 2 , wherein the mammal is a domestic animal. 4. The method according to claim 2 , wherein the mammal is human. 5. The method according to claim 1 , wherein m represents 1 or 2. 6. The method according to claim 1 , wherein m represents 1, each Y may be the same or different, and represents a halogen atom or a (C 1 -C 6 )alkyl group optionally substituted by a halogen atom, and n represents an integer of 1 to 3. 7. The method according to claim 1 , wherein the carboxamide derivative represented by the general formula (I) is a compound of the formula: 8. The method according to claim 1 , wherein the endoparasite is Haemonchus contortus.
Related publications grouped by family.
Answers are generated from the same data shown on this page.